Documents
Application Sponsors
NDA 203108 | BOEHRINGER INGELHEIM | |
Marketing Status
Application Products
001 | SPRAY, METERED;INHALATION | EQ 0.0025MG BASE/INH | 1 | STRIVERDI RESPIMAT | OLODATEROL HYDROCHLORIDE |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2014-07-31 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2016-06-09 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2018-04-02 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2019-05-29 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 6 |
SUPPL | 3 | Null | 15 |
SUPPL | 6 | Null | 6 |
SUPPL | 8 | Null | 6 |
CDER Filings
BOEHRINGER INGELHEIM
cder:Array
(
[0] => Array
(
[ApplNo] => 203108
[companyName] => BOEHRINGER INGELHEIM
[docInserts] => ["Medication Guide",""]
[products] => [{"drugName":"STRIVERDI RESPIMAT","activeIngredients":"OLODATEROL HYDROCHLORIDE","strength":"EQ 0.0025MG BASE\/INH","dosageForm":"SPRAY, METERED;INHALATION","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"05\/29\/2019","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/203108s008lbl.pdf\"}]","notes":""},{"actionDate":"04\/02\/2018","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/203108s006lbl.pdf\"}]","notes":""},{"actionDate":"06\/09\/2016","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/203108s003lbl.pdf\"}]","notes":""},{"actionDate":"07\/31\/2014","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/203108s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"07\/31\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/203108s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/203108Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2014\\\/203108Orig1s000TOC.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2014\\\/203108Orig1s000SumR.pdf\"}]","notes":">"}]
[supplements] => [{"actionDate":"05\/29\/2019","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/203108s008lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/203108Orig1s008ltr.pdf\"}]","notes":">"},{"actionDate":"04\/02\/2018","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/203108s006lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/203108Orig1s006ltr.pdf\"}]","notes":">"},{"actionDate":"06\/09\/2016","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/203108s003lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/203108Orig1s003ltr.pdf\"}]","notes":">"}]
[actionDate] => 2019-05-29
)
)